Healthcare / Medical Care FacilitiesTel Aviv
$1452.00
-28.00 (-1.89%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $63.6M · quality 73.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
9.7x
↓EV/EBITDA
708.5x
↑ROE
8.6%
↑Gross Margin
66.0%
↑Debt/Equity
0.08
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.6%
FCF CAGR
+29.7%
FCF margin
58.0%
FCF / Net income
0.60x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $109.6M · net income $106.7M · FCF $63.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $109.6M | $109.6M | $103.4M | $99.1M | $93.0M |
| Net Income | $106.7M | $106.7M | $133.2M | $125.7M | $97.0M |
| EBITDA | $143.5M | $143.5M | $175.3M | $170.3M | $128.0M |
| EPS | — | — | 1.90 | 1.80 | 1.44 |
| Gross Margin | 66.0% | 66.0% | 67.1% | 68.7% | 68.6% |
| Operating Margin | 41.2% | 41.2% | 41.3% | 44.1% | 45.1% |
| Net Margin | 97.4% | 97.4% | 128.8% | 126.8% | 104.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.08 | 0.08 | — | — | 0.06 |
| Current Ratio | 0.39 | 0.39 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $63.6M | $63.6M | $67.4M | $41.0M | $29.1M |
| Returns | |||||
| ROE | 8.6% | 8.6% | 11.5% | 11.9% | 10.2% |
| Valuation | |||||
| P/E | 9.68 | 9.68 | 761.58 | 565.56 | 749.31 |
| EV/EBITDA | 708.45 | 708.45 | 576.71 | 417.56 | 568.74 |
| P/B | 82.06 | 82.06 | 87.51 | 67.66 | 76.26 |
| Growth & Yield | |||||
| Revenue Growth | 6.0% | 6.0% | 4.3% | 6.6% | — |
| EPS Growth | — | — | 5.6% | 25.0% | — |
| Dividend Yield | 2.7% | 2.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+16.4%
Start / end P/E
n/dx → n/dx
EPS bridge
1.90 → n/d
Residual
+13.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.